Irritation relieving agent, production method thereof and skin external preparation
The use of a sulfated polysaccharide salt with a specific structure, like the sodium salt of Funoran, addresses the challenge of skin irritation from cosmetics and pharmaceuticals by forming a monovalent salt that effectively alleviates irritation, even at low concentrations, as shown in irritation relaxation tests.
Patent Information
- Application Number
- PCT/JP2024/017103
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-09
- Filing Date
- 2024-05-08
- Publication Date
- 2024-11-14
AI Technical Summary
Current cosmetic and pharmaceutical ingredients that typically cause little skin irritation can still cause issues if the skin's barrier function is compromised, and there is a lack of naturally-derived, safe, and stable irritation relievers effective against lactic acid irritation.
A sulfated polysaccharide salt with a specific structure, such as the sodium salt of Funoran, is used, which forms a salt with a monovalent cation and contains sulfate groups in its sugar units, effectively alleviating skin irritation when added to skin preparations.
The sulfated polysaccharide salt significantly reduces skin irritation caused by cosmetics and pharmaceuticals, even at extremely low concentrations, as demonstrated by the irritation relaxation test results.
Smart Images

Figure JP2024017103_14112024_PF_FP_ABST
Abstract
Description
Irritation alleviator, its manufacturing method, and topical skin preparation
[0001] The present invention relates to an irritation-reducing agent to be added to compositions that come into contact with the skin, such as cosmetics and pharmaceuticals, a method for producing the same, and an external skin preparation.
[0002] Because safety is important for cosmetic ingredients, they are used in a concentration range that causes little to no skin irritation. However, if the skin's barrier function is impaired, even ingredients that generally cause little to no skin irritation may cause skin irritation. To mitigate skin irritation, ingredients that repair this skin barrier function and ingredients that mitigate the irritation of other ingredients have been reported. For example, Patent Document 1 discloses that a composition containing a carbohydrate or its derivative as an active ingredient mitigates skin irritation caused by dyes and prevents or prevents inflammation caused by dyes. Specific examples of carbohydrates or their derivatives include one or more selected from the group consisting of monosaccharides, oligosaccharides, and polysaccharides.
[0003] Furthermore, Patent Document 2 discloses that a polysaccharide (levan) produced by the action of a microbial enzyme has the effect of alleviating skin irritation. Levan is a fructose polymer with β(2→6) bonds, and is produced by various microorganisms such as Bacillus subtilis using sucrose as a substrate. However, there has not yet been a naturally derived irritation alleviator that sufficiently suppresses the irritation caused by lactic acid, a typical irritant in cosmetics, and that is itself safe and stable.
[0004] JP-T-2013-511512 A JP-A-2003-277225
[0005] The present invention has been made in view of the above circumstances, and has as its object to provide an irritation alleviator which is highly safe and has excellent irritation suppressing properties.
[0006] As a result of intensive research to solve the above problems, the inventors have discovered that funori polysaccharides extracted from funori by a specific extraction method contain polysaccharide molecules with specific structures that exhibit excellent functionality, and that adding these to topical skin preparations can alleviate irritation caused by pharmaceuticals and cosmetics.
[0007] (1) An irritation mitigator comprising a sulfated polysaccharide salt having a sulfate group in at least one sugar unit structure, and wherein the sulfate group forms a salt with a monovalent cation. (2) The irritation mitigator according to (1), wherein the sulfated polysaccharide salt has one or more hexose structural units selected from the group consisting of fucose, rhamnose, galactose, glucose, mannose, and fructose, and at least one of the hexose structural units has a sulfate group. (3) The irritation mitigator according to (1), wherein the sulfated polysaccharide salt is the sodium salt of funoran, a polysaccharide derived from Funori. (4) A topical skin preparation comprising the irritation mitigator according to any one of (1) to (3) in an amount of 0.000001% by mass to 0.01% by mass, calculated as the solid content of the sulfated polysaccharide salt. (5) A method for producing an irritation reducer, comprising the steps of: dissolving funori powder in water to prepare a funori aqueous solution; adding monovalent cations to the funori aqueous solution and heating the solution; and recovering sulfated polysaccharide salts from the heated aqueous solution. (6) A method for producing an irritation reducer, comprising the steps of dissolving funori powder in water to prepare a funori aqueous solution; adding an acid to the funori aqueous solution to acidify it, followed by desalting; neutralizing the desalted aqueous solution by adding monovalent cations; and recovering sulfated polysaccharide salts from the neutralized aqueous solution.
[0008] The irritation-reducing agent according to the present invention can reduce skin irritation caused by pharmaceuticals and cosmetics even when used in extremely small amounts.
[0009] FIG. 1 shows the results of the irritation alleviation test of Funoran Na carried out in Example 1.
[0010] Below, we will explain in detail the irritation-reducing agent and its manufacturing method according to embodiments of the present invention, as well as the topical skin preparation containing this irritation-reducing agent, but not all of the elements and combinations thereof described in each embodiment are necessarily essential to the solution of the present invention.
[0011] (Irritation Reducer) The irritation reducer according to this embodiment is characterized by comprising, as an active ingredient, a sulfated polysaccharide salt having a sulfate group in at least one sugar unit structure, and in which this sulfate group forms a salt with a monovalent cation. The structure of the polysaccharide constituting this sulfated polysaccharide salt is not particularly limited, as long as it has a sulfate group in at least one sugar unit structure. The sugar unit structure preferably contains a hexose, and may be a homopolysaccharide composed of one type of hexose structural unit, or a heteropolysaccharide containing at least one type of hexose structural unit and two or more types of sugar structural units.
[0012] In the case of heteropolysaccharides, the sugar building blocks other than the at least one hexose building block may be any of triose building blocks, tetraose building blocks, pentose building blocks, or hexose building blocks, and any combination of these may constitute two or more sugar building blocks.
[0013] The hexose structural unit contained in the polysaccharide constituting the sulfated polysaccharide salt according to this embodiment is not particularly limited and may be, for example, any of fucose, rhamnose, galactose, glucose, mannose, and fructose, including those having one or more hexose structural units among these, as long as at least a portion of the hexose structural units has a sulfate group.
[0014] The sulfated polysaccharide salt according to this embodiment may have a sulfate group at any position in the sugar unit structure of the polysaccharide constituting the salt, and may have a sulfate group at, for example, the 2-, 3-, 4-, 5-, and / or 6-position of the hexose structural unit, preferably at the 4- and / or 6-position, and most preferably at the 6-position. For example, the OH at the 4-position of fucose or the OH at the 6-position of galactose may be sulfated (hemisulfate ester).
[0015] Furthermore, the sugar unit structure of the polysaccharide constituting the sulfated polysaccharide salt according to this embodiment is not particularly limited as long as at least a portion of the hexose structural units has a sulfate group, but it is desirable that the structural units having a sulfate group account for, for example, 0.1 to 100%, preferably 1 to 100%, 10 to 100%, 30 to 100%, 40 to 100%, or 50 to 100% of all sugar unit structures constituting the sulfated polysaccharide salt. Furthermore, as long as 50% or more, preferably 60% or more, 70% or more, 80% or more, 90% or more, or 95% or more of all sugar unit structures have hexose structural units having a sulfate group, the effect is substantially the same as when 100% of all sugar unit structures have sugar unit structures having a sulfate group.
[0016] The sulfated polysaccharide salt according to this embodiment further contains a monovalent cation, for example, Na + , K. + , N.H. 4 + etc., preferably Na + and K. + , particularly preferably Na + That is, the polysaccharides having sulfate groups as described above cannot exhibit their intended functions unless they are in the form of a salt due to autohydrolysis, and the counter ion for forming the salt is, for example, Ca. 2+ It has been revealed that when a divalent cation such as calcium is used, even sulfated polysaccharide salts having sulfate groups in the sugar unit structure do not exhibit an irritation-reducing function, such as mitigating irritation to the skin caused by pharmaceuticals or cosmetics, and that only a monovalent cation salt exhibits such an irritation-reducing function. Therefore, it is preferable that the sulfated polysaccharide salt of the present invention is substantially free of divalent cations such as calcium. Here, "substantially free" means, for example, that the amount present is 5% or less, 1% or less, 0.1% or less, 0.01% or less, or 0.001% or less, on a molar basis, and more preferably an amount as close to zero or less.
[0017] The sulfated polysaccharide salt according to the present invention may be synthesized or extracted from various natural sources, as long as it has the structure described above. However, natural products are preferred, and in particular, products derived from funori (scientific name: funoran) are desirable. Funori is a type of seaweed belonging to the red algae family, Gloiopeltis, and genus Gloiopeltis. In Japan, the well-known species are Fukurofunori, Mafunori, and Hanafunori. The funori used in the present invention may be obtained by removing foreign matter from these seaweeds, appropriately purifying them, drying them, and then shearing or powdering them. Alternatively, the funori may be obtained by first obtaining an extract and then granulating or powdering it.
[0018] Although not particularly limited, examples of sulfated polysaccharide salts related to the sodium salt of funoran include those having the structural formula shown below. (However, in these formulas, n is 1 to 20,000, more preferably, for example, 1 to 10,000, 10 to 8,000, 100 to 5,000, 200 to 4,000, or 1,000 to 2,000.)
[0019] The irritation-reducing agent according to this embodiment contains the sulfated polysaccharide salt described above, and its content can be adjusted to a desired concentration of 0.00001% by mass to 99% by mass, calculated as the solid content of the sulfated polysaccharide salt. The irritation-reducing agent according to this embodiment is an ingredient that reduces the irritation of other ingredients, and is preferably used as an additive for producing pharmaceuticals or cosmetics containing desired active ingredients.
[0020] (External Skin Preparation) The external skin preparation according to this embodiment contains the above-mentioned irritation alleviator. Examples of external skin preparations according to this embodiment include basic cosmetics such as lotion, emulsion, cream, ointment, lotion, oil, and pack, skin cleansers such as soap, cleansing cream, cleansing lotion, and face wash, hair washing cosmetics such as shampoo, rinse, and treatment, hair styling products such as hair cream, hair spray, hair tonic, hair gel, hair lotion, hair oil, hair essence, hair water, hair wax, and hair foam, hair growth and care products, foundation, and face powder. makeup cosmetics such as powder, lipstick, blush, eye shadow, eyeliner, mascara, eyebrow pencil, eyelashes, etc.; finishing cosmetics such as nail polish, etc.; cosmetic compositions such as perfumes, toothpastes, oral compositions such as mouthwash, etc.; medicated oral compositions such as topical medicated preparations, ointments, poultices, bath additives, medicated toothpastes, mouth fresheners, etc.; medicated cosmetics; hair dyes, hair growth agents, hair loss prevention agents, hair removers, etc.; external quasi-drugs such as hygiene products, sanitary cotton, wet tissues, etc.; and topical pharmaceuticals.
[0021] The content of the irritation-reducing agent in the topical skin preparation according to this embodiment is not particularly limited, but even a very small amount, such as 0.000001% by mass or more, preferably 0.00001% by mass or more, and more preferably 0.0001% by mass or more, calculated as the solid content of sulfated polysaccharide salt relative to the total amount of the topical skin preparation in the form of an aqueous solution, can provide a very good skin irritation-reducing effect. The upper limit of the amount is also not particularly limited, but from an economical standpoint, it is desirable to use, for example, 0.1% by mass or less, particularly 0.05% by mass, and even more preferably 0.01% by mass or less. A particularly preferred range is 0.00005% by mass to 0.0005% by mass.
[0022] In addition to the above-mentioned ingredients, the above-mentioned topical skin preparations can contain various cosmetic ingredients selected appropriately from the following depending on the required efficacy and effect: Examples include commonly used oils and fats, surfactants, moisturizers, whitening agents, pH adjusters, binders and thickeners, polyhydric alcohols, essential oils and fragrances, preservatives, antioxidants, ultraviolet absorbers, pigments, crushed plant products and herbal medicines, inorganic salts and inorganic acids, detergents, emulsifiers, etc.
[0023] Examples of the oils and fats include those commonly used in cosmetics, such as vegetable oils and fats such as soybean oil, almond oil, paraffin, cetanol, avocado oil, olive oil, jojoba oil, coconut oil, palm oil, rice bran oil, egg yolk oil, castor oil, squalane, lanolin, liquid paraffin, and white petrolatum; animal oils and fats such as beef tallow, lard, horse fat, turtle oil, mink oil, Purcellin oil, and squalane; and synthetic oils and fats such as methylpolysiloxane, behenyl alcohol, glyceryl tricaprate, glyceryl trioctanoate, liquid paraffin, DHA, and EPA.
[0024] Examples of the surfactant include anionic surfactants such as sodium lauryl sulfate, triethanolamine lauryl sulfate, and lauric acid diethanolamide; cationic surfactants such as stearyltrimethylammonium chloride, cetyltrimethylammonium chloride, and benzalkonium chloride; nonionic surfactants such as glyceryl monostearate, sorbitan monostearate, polyoxyethylene (20) sorbitan monostearate, polyoxyethylene hydrogenated castor oil, sucrose esters, and fatty acid amides; polymeric surfactants, fluorine-based surfactants, silicone-based surfactants, polypeptide derivatives, and natural surfactants.
[0025] Examples of the moisturizing agent include synthetic moisturizing agents such as sodium pyrrolidone carboxylate and pantetheine-S sulfonate; and natural moisturizing agents such as hyaluronic acid, elastin, keratin, dermatan sulfate, collagen, placenta extract, royal jelly and hydrolysates thereof, microbial fermentation liquids such as chitin, chitosan, pectin, glucosamine, and N-acetylglucosamine, as well as other plant- or animal-derived extracts, vegetable oils and their esters and derivatives.
[0026] Examples of the whitening agent include ascorbic acid and its salts and derivatives, arbutin and derivatives thereof, placenta extract, and other extracts derived from plants or animals.
[0027] Examples of the pH adjuster include organic acids such as citric acid, lactic acid, salicylic acid, tartaric acid, malic acid, benzoic acid, sodium citrate, fumaric acid, sodium monohydrogen phosphate, and potassium dihydrogen phosphate, as well as inorganic acids and salts thereof.
[0028] Examples of the binders and thickeners include those commonly used in cosmetics, such as sodium carboxymethylcellulose, methylcellulose, casein, pectin, starch, sodium alginate, polyvinyl alcohol, polyvinylpyrrolidone, locust bean gum, agar, carbopol, xanthan gum, and bentonite.
[0029] Examples of the polyhydric alcohols include glycerin, propylene glycol, sorbitol, polyethylene glycol, 1,3-butylene glycol, dipropylene glycol, and polyoxyethylene glycerin (26E.O).
[0030] Examples of the essential oils and fragrances include natural and synthetic fragrances such as lavender oil, jasmine oil, rose oil, lemon oil, orange oil, peppermint oil, thyme oil, calamus oil, fennel oil, cedar oil, hiba oil, raspberry oil, cypress oil, rose oil, eucalyptus oil, camphor, peppermint oil, spearmint oil, geraniol, mandarin oil, spruce oil, citronellol, terpenes, coffee oil, tea oil, camellia oil, and raspberry ketone.
[0031] Examples of the preservative include paraoxybenzoic acid esters such as methylparaben, ethylparaben, propylparaben, and butylparaben, phenoxyethanol, ethanol, and dehydroacetic acid.
[0032] Examples of the antioxidant include EDTA 4Na, EDTA 2Na, butyloxytoluene, hydroxybutyltoluene, butylhydroxyanisole (BHA), dibutylhydroxytoluene (BHT), and derivatives thereof.
[0033] The ultraviolet absorber is not particularly limited as long as it has the property of selectively absorbing ultraviolet light, and examples thereof include oxybenzone, oxybenzonesulfonic acid, tetrahydroxybenzophenone, dihydroxymethoxybenzophenone sodium sulfonate, dihydroxymethoxybenzophenone, dihydroxybenzophenone, cinoxate, methyl diisopropylcinnamate, octyl methoxycinnamate, glyceryl para-aminobenzoate, and octyl para-aminobenzoate.
[0034] Examples of the pigment include red iron oxide, yellow iron oxide, black iron oxide, titanium oxide, nylon powder, zinc oxide, sericite, mica, talc, carbon, and medicinal charcoal.
[0035] Examples of the above-mentioned crushed plants and herbal medicines include crushed products of lemon peel, seaweed, cypress, Japanese cypress, fucus, rice bran, calamus, ginger, licorice, tangerine peel, yuzu, angelica tree, carrot, mint, cinnamon bark, Ubai, mugwort, Houttuynia cordata, peach blossom, chamomile, aloe, jasmine, rose hip, lavender, guava, Scutellaria root, wolfberry, lychee, elderberry, Angelica tree, Aralia aralia, burdock, black sesame, black rice, Fujisanchi ginseng, Korean ginseng, Panax notoginseng, Sekkotsu grass, Cnidium rhizome, etc., as well as dried products and extracts thereof.
[0036] Examples of the inorganic salts and inorganic acids include sodium chloride, sodium bicarbonate, sodium carbonate, boric acid, borax, sodium sulfate, sodium sulfide, potassium sulfide, sodium nitrate, calcium nitrate, ammonium sulfate, sodium thiosulfate, calcium hydrogen phosphate, potassium chloride, ammonium chloride, sodium phosphate, sodium hyposulfite, calcium thiosulfate, sulfur, sodium sesquicarbonate, magnesium sulfate, magnesium chloride, silicic anhydride, metasilicic acid, boric acid, magnesium carbonate, magnesium hydroxide, magnesium dihydride, dried seawater, and the like.
[0037] Examples of the detergent include fatty acid soap, sodium lauryl sulfate, anionic surfactants such as alkyl ether carboxylates, and aliphatic detergents.
[0038] The emulsifier may be any known cosmetic raw material. Particularly preferred emulsifiers include sucrose fatty acid esters such as sucrose laurate, sucrose myristate, sucrose palmitate, sucrose stearate, sucrose oleate, and sucrose erucate; tetraglycerin monostearate, tetraglycerin monooleate, tetraglycerin tristearate, hexaglycerin monolaurate, hexaglycerin monomyristate, hexaglycerin monostearate, hexaglycerin tristearate, decaglycerin monolaurate, decaglycerin monomyristate, decaglycerin monostearate, decaglycerin distearate, and decaglycerin monostearate. polyglycerol fatty acid esters such as sorbitan tristearate, decaglycerol pentastearate, decaglycerol monoisostearate, decaglycerol diisostearate, decaglycerol pentaisostearate, decaglycerol monooleate, decaglycerol trioleate, and decaglycerol pentaoleate; sorbitan branched fatty acid esters such as sorbitan monoisostearate, sorbitan sesquiisostearate, and sorbitan triisostearate; lecithins such as soybean lecithin, egg yolk lecithin, hydrogenated soybean lecithin, hydrogenated egg yolk lecithin, and further lysolecithin and / or hydrogenated lysolecithin obtained by enzymatically treating these lecithins to form monoacylated forms, and hydroxylated hydroxylecithin; and glycerol branched fatty acid esters such as glyceryl monoisostearate, glyceryl sesquiisostearate, and glyceryl diisostearate, and more may be used in combination of one or more thereof.
[0039] Furthermore, in addition to the above, the above-mentioned topical skin preparations may contain other ingredients as needed, such as milk-derived ingredients such as lactose, milk, and condensed milk; inorganic pigments such as titanium and talc; disinfectants such as isopropylmethylphenol, chlorhexidine hydrochloride, and chlorhexidine gluconate; vitamins and coenzymes such as vitamin A, vitamin B1, vitamin B2, vitamin B6, vitamin P, CoQ10, CoQ9, CoQ8, and thioctic acid, fluidizing agents such as silicic anhydride and synthetic aluminum silicate; and tar-based pigments for pharmaceuticals, quasi-drugs, and cosmetics.
[0040] In addition to the above-mentioned ingredients, the above-mentioned external skin preparations can also contain various cosmetic ingredients such as medicinal ingredients for the purposes of beauty, facial beauty, and skin treatment, as appropriate. The medicinal ingredients include avocado extract, hydrangea extract, althea extract, arnica extract, apricot extract, apricot kernel extract, ginkgo extract, fennel extract, turmeric extract, oolong tea extract, echinacea leaf extract, phellodendron bark extract, barley extract, Dutch mustard extract, orange extract, hydrolyzed wheat powder, hydrolyzed silk, chamomilla extract, carrot extract, artemisia capillaris extract, kalkade extract, kiwi extract, cinchona extract, cucumber extract, guanosine, bracken extract, walnut extract, grapefruit extract, clematis extract, yeast extract, comfrey extract, cowberry extract, bupleurum extract, umbilical cord extract, salvia extract, soapwort extract, bamboo extract, hawthorn extract, shiitake mushroom extract, rehmannia root extract, lithospermum root extract, linden extract, meadowsweet extract, calamus root extract, white birch extract, horsetail extract, honeysuckle Examples of effective skin care products include laurel extract, common weed extract, hawthorn extract, elderberry extract, yarrow extract, peppermint extract, mallow extract, Swertia japonica extract, Chinese laurel extract, thyme extract, clove extract, Imperata cylindrica extract, tomato extract, natto extract, wild rose extract, hibiscus extract, Bakumondo extract, parsley extract, Parietaria extract, Japanese knotweed extract, bisabolol, coltsfoot extract, butterbur honey, Japanese gourd extract, Poria columbine extract, butcher's broom extract, grape extract, propolis, loofah extract, peppermint extract, linden extract, hop extract, pine extract, horse chestnut extract, Asian skunk cabbage extract, soapberry extract, peach leaf extract, cornflower extract, eucalyptus extract, apple extract, lettuce extract, astragalus extract, rose extract, rosemary extract, and Roman chamomile extract.
[0041] In addition, anti-inflammatory agents such as ε-aminocaproic acid, glycyrrhizinic acid, dipotassium glycyrrhizinate, β-glycyrrhetinic acid, lysozyme chloride, guaiazulene, and hydrocortisone; blood circulation promoters such as vitamin C, vitamin D, calcium pantothenate, biotin, nicotinamide, vitamin E, and vitamin E derivatives; vitamins such as β-carotene and carotenoid derivatives; active ingredients such as allantoin, diisopropylamine dichloroacetate, and 4-aminomethylcyclohexanecarboxylic acid; antioxidants such as flavonoids, tannins, lignans, and saponins; wound healing agents such as γ-oryzanol and protease; cepharanthine, capsicum tincture, hinokitiol, and garlic iodide. Extracts, pyridoxine hydrochloride, nicotinic acid, nicotinic acid derivatives, acetyl pantothenyl ethyl ether, estradiol, ethinyl estradiol, capronium chloride, diphenhydramine hydrochloride, camphor, nonylic acid vanillylamide, nonanoic acid vanillylamide, piroctone olamine, glyceryl pentadecanoate, 1-menthol, menthol pyrrolidonecarboxylate, mononitroguaiacol, urea, resorcinol, γ-aminobutyric acid, benzethonium chloride, mexiletine hydrochloride, auxin, female hormones and female hormone-like substances, cantharides tincture, cyclosporine, analgesics, tranquilizers, antihypertensives, antibiotics, antihistamines, antibacterial substances, and the like may also be optionally blended.
[0042] The subject of administration of the external skin preparation of this embodiment is preferably a warm-blooded vertebrate, more preferably a mammal.In this specification, the mammal includes, for example, humans, and non-human mammals such as monkeys, mice, rats, rabbits, dogs, cats, cows, horses, and pigs.The external skin preparation of this embodiment is preferably applied to human subjects who wish to improve skin irritation.
[0043] (Production Method) The sulfated polysaccharides constituting the active ingredient of the irritation alleviator according to this embodiment can be produced from natural plant materials such as algae. The natural plant material is powdered and dissolved in water. A salt that forms monovalent ions, such as sodium chloride, is added to the solution, and the solution is heated. After heating, the monovalent ion salt of the sulfated polysaccharide can be isolated by separating the mixture based on molecular weight.
[0044] Here, the term "natural plant material" refers to any plant found in nature, including algae. Examples of natural plant materials include, but are not limited to, brown algae (e.g., Laminaria, Undaria pinnatifida, Lessonia, Macrocystis, Ecklonia, Arame, Ascophyllum, Durvillea, etc.), red algae (e.g., Eucheuma, Porphyra, Gelidium, Gracilaria, Porphyra, Porphyra, etc.), and green algae (e.g., Myrtle, Ulva, Enteromorpha, Cholesterol, and Astragalus, etc.). Other plants include, but are not limited to, citrus fruits, sugar beets, apples, etc. Of these, algae, particularly red algae, are preferred, and a representative example is that made from seaweed of the genus Funori.
[0045] In a preferred embodiment, the method for producing the irritation alleviator includes the steps of dissolving funori powder in water to prepare a funori aqueous solution, adding monovalent cations to the funori aqueous solution and heating it, and recovering sulfated polysaccharide salts by molecular weight fractionation of the heated aqueous solution. Instead of the heating step, the method may include the steps of adding an acid (hydrochloric acid, sulfuric acid, or an organic acid) to the funori aqueous solution to acidify it, followed by desalting, and adding monovalent cations to the desalted aqueous solution to neutralize it. Then, by separating the solution by molecular weight, sulfated polysaccharide salts salified with monovalent cations can be recovered.
[0046] The salt that becomes the monovalent cation used in the heating step is not particularly limited, but examples thereof include sodium chloride, potassium chloride, sodium sulfate, potassium sulfate, etc. The amount of these salts added to the hot water is not particularly limited, but is, for example, 0.0001 to 10 mol / L, further, for example, 0.001 to 5 mol / L, 0.01 to 2 mol / L, and preferably 0.1 to 1 mol / L.
[0047] The temperature of the hot water in the heating step is not particularly limited, but is, for example, 40°C or higher, and further, for example, 50°C or higher, 60°C or higher, 70°C or higher, 80°C or higher, 90°C or higher, 100°C or higher, or 120°C or higher. A specific example is a heating step using water as a solvent at normal pressure (1013 hPa±50 hPa) and a temperature of 100°C or lower, for example, 55 to 65°C.
[0048] The time required for this heating may vary depending on the temperature selected, but may be from 1 hour to 2 months, for example, 1 hour to 1 month, 1 hour to 15 days, 1 hour to 10 days, 1 hour to 5 days, 1 hour to 3 days, 1 hour to 2 days, 1 hour to 1 day, 5 hours to 1 month, 5 hours to 15 days, 5 hours to 10 days, 5 hours to 5 days, 5 hours to 3 days, 5 hours to 2 days, 5 hours to 1 day, 10 hours to 1 month, 10 hours to 15 days, 10 hours to 10 days, 10 hours to 5 days, 10 hours to 3 days, or 10 hours to 2 days.
[0049] The heating step may include mixing the raw material funori in water containing monovalent cations as a solvent and leaving it for a certain period of time. This leaving may include appropriate stirring.
[0050] The heating step is repeated one or more times, for example, 1 to 5 times. For example, it can be performed one or more times at 40 to 50°C, 50 to 60°C, 60 to 70°C, 70 to 80°C, or 50 to 70°C. Furthermore, when extraction is performed multiple times, the temperature for each time may be different or the same, and it is also possible to gradually increase the temperature with each time. Preferably, the temperature is 50 to 60°C or higher, and more preferably 55°C or higher.
[0051] In the heating step, if necessary, techniques such as pressurized liquid extraction (PLE), microwave-assisted extraction (MAE), subcritical extraction (SE), or a combination thereof can be used in combination. Subcritical extraction is subcritical water extraction (SWE). Subcritical water extraction is also called superheated water extraction or pressurized hot water extraction (PHWE).
[0052] Subsequently, the sulfated polysaccharide salt can be recovered by, for example, molecular weight fractionation of the solution after the heating step or neutralization step using a molecular weight fractionation membrane or gel filtration. As a molecular weight fractionation membrane, molecular weight fractionation can be carried out industrially using an ultrafiltration membrane. For example, molecular weight fractions within a predetermined range can be prepared by using an MF membrane (microfiltration membrane) or UF membrane (ultrafiltration membrane) such as Microza (trade name) manufactured by Asahi Kasei Corporation. As an example of gel filtration, Cellulofine GCL-300 manufactured by Seikagaku Corporation can be used. Furthermore, any molecular weight fraction can be prepared by combining these molecular weight fractionation methods and gel filtration methods.
[0053] The irritation-reducing agent produced by the method of this embodiment can be further mixed with a pharmacologically or cosmetically acceptable carrier to produce a topical skin preparation. The topical skin preparation and pharmacologically or cosmetically acceptable carrier are as described above.
[0054] The present invention will be described in more detail below with reference to examples, but the present invention is not limited to these examples. In the following examples, the unit % used to indicate the amount of each component added means % by mass.
[0055] (Production Example 1) Water was added to powdered dried seaweed funori seaweed, and the mixture was dissolved to loosen the entangled structure of the components. The dissolved and insoluble portions were precisely separated to form single molecular units. Sodium chloride was added to the solution, and the mixture was heated. After heating, the mixture was separated by molecular weight to extract the sodium salt of 6-position O-sulfated polysaccharide (hereinafter referred to as "funoran Na"). Structural analysis of funoran Na was performed by analyzing the reducing end sugar and sugar composition using a fluorescent labeling method with 2-aminopyridine, analyzing the sulfate content using turbidimetry with barium chloride, and NMR analysis. It was confirmed that funoran Na contains D-galactose as a sugar building block, and that at least a portion of these D-galactose sugar building blocks have a sulfate group at the 6-position. An aqueous solution containing 0.01 to 0.001% of the resulting 6-position O-sulfated polysaccharide sodium salt was prepared and used as a sample.
[0056] (Production Example 2) Funori (seaweed) was powdered and dissolved in water. Hydrochloric acid was added to the solution to make it acidic, and the solution was then desalted and neutralized with sodium hydroxide. After desalting again, the solution was separated by molecular weight, and the sodium salt of 6-position O-sulfated polysaccharide (funoran Na) was isolated.
[0057] (Example 1) Irritation alleviation test of Funoran Na <Subjects> Ten Japanese women aged between 20 and 60 at the time of consent, who were aware of having sensitive skin that is easily irritated, participated in this test. These subjects had an average score of 2 or more when stimulated with 5% lactic acid, the positive control in the skin irritation test using the following test method.
[0058] <Test Method> The skin irritation test was conducted using human skin. After washing the face with warm water, the subject was allowed to stand in a quiet room for 20 minutes to acclimate. As a positive control, an appropriate amount (approximately 20 μl) of a 5% lactic acid solution (5 g of cosmetic lactic acid dissolved in distilled water to make 100 mL) was applied to the right cheek. The irritation felt immediately after application (30 seconds), 2 minutes after application, and 5 minutes after application was scored according to the following criteria. After the evaluation, the test area was quickly rinsed with cold or warm water without rubbing.
[0059]
[0060] The evaluation score was the average score obtained by dividing the total scores immediately after application (30 seconds later), 2 minutes after application, and 5 minutes after application by the number of observations (3). The subjects were instructed to concentrate on the test without talking during the test, as the test involved observing a weak stimulus.
[0061] <Irritation alleviation test> A 5% lactic acid solution containing 1 ppm of Funoran Na was prepared as the test product using the sample prepared in Production Example 1. Approximately 20 μl of this test product was applied to the skin of the subject, and the average scores were recorded immediately after application (30 seconds), 2 minutes after application, and 5 minutes after application, as in the skin irritation test. After the evaluation was completed, the test area was quickly rinsed with cold or warm water without rubbing.
[0062] <Test Results> The results of the evaluation based on the same evaluation criteria as in Table 1 are shown in Table 2 below and FIG.
[0063] As shown in Table 2 and Figure 1, it was found that the average score was significantly lower when a sample containing 1 ppm of funoran Na was applied compared to when a 5% lactic acid solution used as a positive control was applied.
[0064] Example 2 Using a 5% lactic acid solution (approximately 20 μl) containing 0.1 ppm or 0.01 ppm of funoran Na, an irritation alleviation test was carried out in the same manner as in Example 1. The results are shown in Table 3 below.
[0065]
[0066] As shown in Table 3, when Funoran Na was added at 0.1 ppm or 0.01 ppm, the average score tended to decrease compared to the positive control. These skin irritation assessment results demonstrated that the irritation-reducing effect of Funoran Na decreased in a concentration-dependent manner at 0.1 ppm or less, and that the irritation-reducing effect was confirmed at 1 ppm or more. This demonstrates that adding Funoran Na at 0.01 to 1 ppm to substances or products that may irritate the skin is effective as an irritation-reducing material.
[0067] The irritation-reducing agent of the present invention may be added in extremely small amounts to any cosmetic product, such as a skin care product or a makeup product, and may provide external skin preparations, such as pharmaceuticals and cosmetics, that can be freely used without discomfort by people who have previously experienced skin discomfort from cosmetic products.
Claims
1. An irritation-relieving agent comprising a sulfated polysaccharide salt having a sulfate group in at least one sugar unit structure, said sulfate group forming a salt with a monovalent cation.
2. The irritation-relieving agent according to claim 1, wherein the sulfated polysaccharide salt has one or more hexose structural units selected from the group consisting of fucose, rhamnose, galactose, glucose, mannose and fructose, and at least one of the hexose unit structures has a sulfate group.
3. The irritation-relieving agent according to claim 1, wherein the sulfated polysaccharide salt is the sodium salt of funoran, a polysaccharide derived from Funori.
4. A skin topical preparation containing the irritation-relieving agent according to any one of claims 1 to 3 in an amount of 0.000001% by mass to 0.01% by mass, calculated as the solid content of the sulfated polysaccharide salt.
5. A method for producing an irritation alleviator, comprising the steps of: dissolving funori powder in water to prepare a funori aqueous solution; adding a monovalent cation to the funori aqueous solution and heating it; and molecular weight fractionating the heated aqueous solution to recover sulfated polysaccharide salts.
6. A method for producing an irritation-relieving agent, comprising the steps of: dissolving funori powder in water to prepare a funori aqueous solution; adding an acid to the funori aqueous solution to make it acidic, and then desalting it; neutralizing the desalted aqueous solution by adding a monovalent cation; and molecular weight fractionating the neutralized aqueous solution to recover sulfated polysaccharide salts.
Citation Information
Patent Citations
External agent for skin
JP1995196443A
Mucopolysaccharide of glue and therapeutic agent containing the same as active ingredient
JP1995330804A
Dermal composition for external use
JP1996259443A
Skin cosmetic
JP1996283138A
Skin lightening cosmetic
JP2012121865A
